secwatch.observer — SEC 8-K summary
======================================

Issuer:     Better Therapeutics, Inc. (—)
CIK:        0001832415
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001193125-23-296870
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Therapeutics receives Nasdaq delisting notice; intends to appeal
-----------------------------------------------------------------------

- Nasdaq notified Better Therapeutics on Dec 14, 2023 of delisting effective Dec 26, 2023 due to continued non-compliance with minimum bid price ($1.00) and MVLS ($35M) requirements.
- Company had 180-day compliance period ending Dec 13, 2023 but failed to regain compliance; not eligible for additional extension.
- Company intends to appeal to a Nasdaq Hearings Panel before Dec 21, 2023; appeal will stay delisting pending panel decision.
- No assurance that appeal will succeed or that listing on Nasdaq Capital Market will be maintained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832415/000119312523296870/0001193125-23-296870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832415/000119312523296870/d48627d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-296870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer